In line, in its enzymatically active tetrameric form glycolytic enzyme PKM2 attenuates macrophage M1‐phenotype and skews them to the tumour supportive M2 phenotype (Palsson‐McDermott et al., 2015). Here, PKM is linked to neoplasm.